Polygon Management »

Ionis Pharmaceuticals shares owned by Polygon Management

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.1M 42k 75.09

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Warner Bros Discovery Com Ser A (WBD)
Workiva Com Cl A (WK)
Lyft Cl A Com (LYFT)
Sprinklr Cl A (CXM)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Axsome Therapeutics (AXSM)
Arrowhead Pharmaceuticals (ARWR)
Nektar Therapeutics Com New (NKTR)
Annexon (ANNX)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)
Agios Pharmaceuticals (AGIO)

View all positions for Polygon Management

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
Two Sigma Investments
Bellevue Group
Geode Capital Management
State Street Corporation
Royal Bank of Canada
Tweedy, Browne Company
Artisan Partners Limited Partnership

View all funds holding Ionis Pharmaceuticals